Eyestem raises Series A round led by three pharma majors
The investment will enable Eyestem to progress a treatment for dry age-related macular degeneration to the clinic
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
dry age-related macular degeneration
Eyestem raises funds from global investors in Switzerland, South Africa
The investment will boost Eyestem's efforts to find treatment for dry age-related macular degeneration, leading cause of incurable…